Trial intelligence / Profile preview

Combined intravenous and periarticular tranexamic acid vs intravenous tranexamic acid alone in simultaneous bilateral total knee arthroplasty

TCTR20221229004Phase 3Unknown

Sponsor
Charoenkrung Pracharak Hospital
Start
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tranexamic acid in knee osteoarthritis (OA), sponsored by Charoenkrung Pracharak Hospital. Status: unknown.

02

Drugs

tranexamic acid
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on TCTR20221229004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20221229004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call